The paper by Sharyo et al. shows that statins reduce the severity in a model of renal–ischemia reperfusion injury and raises the therapeutic possibility of using statins as pharmacological intervention against acute kidney injury. This, together with previous studies, indicates that statins exert a wide spectrum of anti-inflammatory, immunomodulatory, and protective effects besides their lipid-lowering function
Potential benefits of statins in the treatment of chronic kidney disease beyond lipid-lowering effec...
Role of hyperlipidemia in progressive renal disease: Focus on diabetic nephropathy.BackgroundIt has ...
The role of lipids in renal disease: future challenges. Experimental studies have provided in vivo a...
During the last two decades, numerous studies have demonstrated that 3-hydroxy-3-methylglutaryl coen...
Chronic kidney disease, especially in the setting of proteinuria, is characterized by hyperlipidemia...
Recent advances in statins and the kidneyBackgroundExperimental and clinical studies have suggested ...
Anti-inflammatory and immunomodulatory effects of statins. 3-Hydroxy-3-methyl-gutaryl coenzyme A (HM...
There has been a great deal of excitement regarding the potential benefits of statins beyond their l...
In addition to cholesterol lowering, 3-hydroxy-3-nethylglutaryl coenzyme A (HMG-CoA) reductase inhib...
BACKGROUND: Statin is an anti-cholesterol drug that is widely prescribed throughout the world. Stati...
Statins, as the most important cholesterol-lowering agents, inhibit the production of blood choleste...
Postischemic acute renal failure (ARF) is common and often fatal. Cellular mechanisms include cell a...
This literature review presents current data on statins as anti-inflammatory agents in atherogenesis...
Statins are known to lessen the severity of renal ischemia-reperfusion injury. The present study was...
Acute kidney injury (AKI) occurs in about half of patients in septic shock and the mortality of AKI ...
Potential benefits of statins in the treatment of chronic kidney disease beyond lipid-lowering effec...
Role of hyperlipidemia in progressive renal disease: Focus on diabetic nephropathy.BackgroundIt has ...
The role of lipids in renal disease: future challenges. Experimental studies have provided in vivo a...
During the last two decades, numerous studies have demonstrated that 3-hydroxy-3-methylglutaryl coen...
Chronic kidney disease, especially in the setting of proteinuria, is characterized by hyperlipidemia...
Recent advances in statins and the kidneyBackgroundExperimental and clinical studies have suggested ...
Anti-inflammatory and immunomodulatory effects of statins. 3-Hydroxy-3-methyl-gutaryl coenzyme A (HM...
There has been a great deal of excitement regarding the potential benefits of statins beyond their l...
In addition to cholesterol lowering, 3-hydroxy-3-nethylglutaryl coenzyme A (HMG-CoA) reductase inhib...
BACKGROUND: Statin is an anti-cholesterol drug that is widely prescribed throughout the world. Stati...
Statins, as the most important cholesterol-lowering agents, inhibit the production of blood choleste...
Postischemic acute renal failure (ARF) is common and often fatal. Cellular mechanisms include cell a...
This literature review presents current data on statins as anti-inflammatory agents in atherogenesis...
Statins are known to lessen the severity of renal ischemia-reperfusion injury. The present study was...
Acute kidney injury (AKI) occurs in about half of patients in septic shock and the mortality of AKI ...
Potential benefits of statins in the treatment of chronic kidney disease beyond lipid-lowering effec...
Role of hyperlipidemia in progressive renal disease: Focus on diabetic nephropathy.BackgroundIt has ...
The role of lipids in renal disease: future challenges. Experimental studies have provided in vivo a...